Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries

Author:   Aloke Virmani Finn, MD (Director and Chief Scientific Officer, CVPath)
Publisher:   Elsevier - Health Sciences Division
ISBN:  

9780443135934


Pages:   252
Publication Date:   14 June 2024
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $435.60 Quantity:  
Add to Cart

Share |

Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries


Add your own review!

Overview

Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries is a thorough review of the disease written by experts studying its detection and treatment. These state-of-the-art chapters summarize emerging knowledge about this important area of medicine. The pathophysiology and treatment of peripheral artery (PAD) disease remains poorly understood even by practitioners. Often it is assumed that PAD should be treated in a similar fashion to coronary artery disease (CAD), when in fact recent data suggest a distinct pathophysiology with genetic risk having some but not complete overlap with CAD. This is a novel reference of emerging data on the factors behind its development and progression, detection, and treatment suggest an emerging paradigm for this disease.

Full Product Details

Author:   Aloke Virmani Finn, MD (Director and Chief Scientific Officer, CVPath)
Publisher:   Elsevier - Health Sciences Division
Imprint:   Elsevier - Health Sciences Division
Weight:   0.530kg
ISBN:  

9780443135934


ISBN 10:   0443135932
Pages:   252
Publication Date:   14 June 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Reviews

Author Information

Dr. Aloke Virmani Finn is a physician-scientist whose focus is on the pathology of cardiovascular disease and its treatment.?He serves as the Medical Director and Chief Scientific Officer for CVPath Institute where he oversees device development research and runs a molecular lab with focus on the molecular understanding of vascular wall injury and healing, genetics of sudden cardiac death and molecular basis of coronary artery disease.? When not running CVPath, he performs interventional cardiology procedures at University of Maryland.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List